Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Price Reaction to Earnings Reports

View detailed tables showing price action before and after earnings announcements, ranging from intraday to one week out. Track how the market has reacted to past earnings to identify patterns and predict future behavior. Click here to open.

LQDA

Liquidia Corp

Dec 10 • 04:00PM ET

10.75

Dollar change -0.25
Percentage change -2.27	%

Healthcare • Biotechnology • USA • NASD

Peers: REGN VRTX ALNY SRPT NBIX ARWR IONS RGEN MDGL XNCR

| Held by: VTI IWM KOMP PJP VXF IWO VTWO SCHA XPH VHT

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-1.62	Insider Own	30.07%	Shs Outstand	84.55M	Perf Week	-4.53%
Market Cap	909.84M	Forward P/E	-	EPS next Y	-1.48	Insider Trans	1.14%	Shs Float	59.19M	Perf Month	-2.54%
Income	-119.47M	PEG	-	EPS next Q	-0.38	Inst Own	54.35%	Short Float	17.84%	Perf Quarter	5.86%
Sales	15.61M	P/S	58.29	EPS this Y	-29.18%	Inst Trans	20.11%	Short Ratio	11.57	Perf Half Y	-22.16%
Book/sh	1.31	P/B	8.22	EPS next Y	5.40%	ROA	-65.55%	Short Interest	10.56M	Perf Year	48.69%
Cash/sh	2.41	P/C	4.45	EPS next 5Y	-	ROE	-150.73%	52W Range	6.86 - 16.99	Perf YTD	-10.64%
Dividend Est.	-	P/FCF	-	EPS past 5Y	30.44%	ROI	-106.71%	52W High	-36.73%	Beta	0.23
Dividend TTM	-	Quick Ratio	6.33	Sales past 5Y	423.30%	Gross Margin	57.24%	52W Low	56.71%	ATR (14)	0.47
Dividend Ex-Date	-	Current Ratio	6.33	EPS Y/Y TTM	-82.56%	Oper. Margin	-715.07%	RSI (14)	47.49	Volatility	5.26% 4.50%
Employees	136	Debt/Eq	0.02	Sales Y/Y TTM	-14.78%	Profit Margin	-765.37%	Recom	1.20	Target Price	25.44
Option/Short	Yes / Yes	LT Debt/Eq	0.01	EPS Q/Q	-21.44%	Payout	-	Rel Volume	1.09	Prev Close	11.00
Sales Surprise	6.99%	EPS Surprise	19.72%	Sales Q/Q	20.94%	Earnings	Nov 13 BMO	Avg Volume	913.01K	Price	10.75
SMA20	-0.15%	SMA50	-0.88%	SMA200	-11.14%	Trades		Volume	990,827	Change	-2.27%

Date	Action	Analyst	Rating Change	Price Target Change
Oct-16-24	Initiated	Scotiabank	Sector Outperform
Aug-19-24	Upgrade	Raymond James	Outperform → Strong Buy
Aug-16-24	Initiated	Raymond James	Outperform	$27
Jun-25-24	Initiated	Oppenheimer	Perform
Jan-05-24	Reiterated	Needham	Buy	$18 → $28
Sep-19-22	Resumed	Wedbush	Underperform	$3
Sep-01-22	Downgrade	Wedbush	Neutral → Underperform	$3
Jul-22-22	Initiated	Ladenburg Thalmann	Buy	$15
May-31-22	Initiated	BTIG Research	Buy	$14
May-26-22	Initiated	BofA Securities	Buy	$12
Dec-04-20	Initiated	H.C. Wainwright	Buy	$6
Nov-20-20	Downgrade	Wedbush	Outperform → Neutral	$20 → $4
Nov-08-18	Resumed	Jefferies	Buy
Sep-05-18	Initiated	Wedbush	Outperform	$26
Aug-20-18	Initiated	Needham	Buy	$30
Aug-20-18	Initiated	Jefferies	Buy	$22

Show Previous Ratings

Nov-26-24 09:55AM	Wall Street Analysts See a 126.13% Upside in Liquidia Technologies (LQDA): Can the Stock Really Move This High? (Zacks)
Nov-14-24 02:09AM	Liquidia Corp (LQDA) Q3 2024 Earnings Call Highlights: Strategic Advances Amidst Regulatory ... (GuruFocus.com)
Nov-13-24 07:40AM	Liquidia Technologies, Inc. (LQDA) Reports Q3 Loss, Tops Revenue Estimates (Zacks)
06:30AM	Liquidia Corporation Reports Third Quarter 2024 Financial Results and Provides Corporate Update (GlobeNewswire)
Nov-12-24 08:00AM	Liquidia to Present at the Stifel 2024 Healthcare Conference (GlobeNewswire)
07:04AM	Loading…
Nov-08-24 07:04AM	Earnings To Watch: Liquidia Corp (LQDA) Reports Q3 2024 Result (GuruFocus.com)
Nov-06-24 08:00AM	Liquidia Corporation to Report Third Quarter 2024 Financial Results on November 13, 2024 (GlobeNewswire)
Nov-04-24 08:00AM	Liquidia Corporation to Report Third Quarter 2024 Financial Results on November 11, 2024 (GlobeNewswire)
Oct-29-24 10:01AM	Liquidia Technologies, Inc. (LQDA) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release (Zacks)
Oct-09-24 05:12PM	Liquidia Corp (LQDA) Q2 2024 Earnings Call Highlights: Navigating Challenges and Opportunities ... (GuruFocus.com)
Oct-08-24 09:34AM	Liquidia Technologies (LQDA) Surges 11.2%: Is This an Indication of Further Gains? (Zacks)
Oct-07-24 10:00AM	United States Supreme Court Declines to Review Rulings that Invalidate United Therapeutics' Patent (GlobeNewswire) +11.17%
Oct-02-24 06:00AM	Liquidia and Pharmosa Biopharm Expand Collaboration to Develop Sustained Release Inhaled Treprostinil (L606) (GlobeNewswire)
Sep-30-24 09:00PM	Bragar Eagel & Squire, P.C. Is Investigating Liquidia, Napco, and Franklin and Encourages Investors to Contact the Firm (GlobeNewswire)
08:00AM	Liquidia Announces Poster Presentation and Medical Theater at the CHEST 2024 Annual Meeting (GlobeNewswire)
09:00PM	Loading…
Sep-16-24 09:00PM	Bragar Eagel & Squire, P.C. Is Investigating Paragon 28, Centuri, Liquidia, and Elastic and Encourages Investors to Contact the Firm (GlobeNewswire)
09:41AM	Court Finds United Therapeutics' Interference with Launch of Generic Treprostinil Injection Caused Losses of More Than $137 Million (GlobeNewswire)
Sep-12-24 07:02PM	Caligan Partners LP Bolsters Portfolio with Significant Stake in Liquidia Corp (GuruFocus.com)
07:00AM	Liquidia Technologies (LQDA) Soars 14.1%: Is Further Upside Left in the Stock? (Zacks)
Sep-11-24 08:26AM	Liquidia Corporation Announces Raise of $67.5 Million from New Common Stock Financings and $32.5 Million Advance from HealthCare Royalty Under Current Financing Agreement (GlobeNewswire) +14.10%
Aug-28-24 08:00AM	Liquidia to Present at Upcoming Investor Conferences (GlobeNewswire)
Aug-26-24 02:19PM	Jim Cramer Says Liquidia Corporation (LQDA) Has Been Going Down, Down, Down (Insider Monkey)
Aug-22-24 06:00AM	Liquidia Files Litigation to Challenge Regulatory Exclusivity Blocking Access to YUTREPIA (treprostinil) inhalation powder for Patients Suffering with PAH and PH-ILD (GlobeNewswire)
Aug-20-24 10:27AM	Liquidia (LQDA) Down on FDA Delaying Full Approval for Yutrepia (Zacks)
06:33AM	Liquidias YUTREPIA inhalation powder gains tentative FDA approval (Pharmaceutical Technology)
Aug-19-24 04:01PM	Why Liquidia Stock Just Reversed Its Seven-Day Sprint And Crashed 31% (Investor's Business Daily) -30.62%
11:11AM	Midday movers: B. Riley, HP Inc fall; AMD rises (Investing.com)
06:00AM	U.S. FDA Grants Tentative Approval of YUTREPIA (treprostinil) Inhalation Powder for Patients with Pulmonary Arterial Hypertension (PAH) and Pulmonary Hypertension Associated with Interstitial Lung Disease (PH-ILD) (GlobeNewswire)
Aug-16-24 06:30AM	Liquidia Announces Poster Presentations at the PHA 2024 International PH Conference and Scientific Sessions (GlobeNewswire)
Aug-09-24 07:45AM	Why Is Liquidia Corporation (LQDA) The Best Among Caligan Partners Top Holdings? (Insider Monkey)
07:40AM	Loading…
Aug-07-24 07:40AM	Liquidia Technologies, Inc. (LQDA) Reports Q2 Loss, Lags Revenue Estimates (Zacks)
06:30AM	Liquidia Corporation Reports Second Quarter 2024 Financial Results and Provides Corporate Update (GlobeNewswire)
Jul-31-24 08:00AM	Liquidia Corporation to Report Second Quarter 2024 Financial Results on August 7, 2024 (GlobeNewswire)
Jun-18-24 08:42AM	Liquidia Announces Poster Presentations at the 7th World Symposia on Pulmonary Hypertension (WSPH) (GlobeNewswire) -6.08%
Jun-03-24 04:33PM	Liquidia Stock Surges After Winning Patent Battle Vs. United Therapeutics (Investor's Business Daily) +12.67%
07:00AM	District Court Issues Favorable Ruling and Denies United Therapeutics' Request to Block YUTREPIA Launch (GlobeNewswire)
May-29-24 08:00AM	Liquidia Corporation to Present at the 2024 Jefferies Global Healthcare Conference (GlobeNewswire)
May-15-24 03:03AM	Liquidia Corp (LQDA) Q1 2024 Earnings Call Transcript Highlights: A Detailed Review of ... (GuruFocus.com)
02:05AM	Q1 2024 Liquidia Corp Earnings Call (Thomson Reuters StreetEvents)
May-14-24 09:35AM	Down -11.26% in 4 Weeks, Here's Why You Should You Buy the Dip in Liquidia Technologies (LQDA) (Zacks)
08:53AM	LQDA Stock Earnings: Liquidia Misses EPS, Misses Revenue for Q1 2024 (InvestorPlace)
May-13-24 05:43PM	Liquidia Corporation Reports First Quarter 2024 Financial Results and Provides Corporate Update (GlobeNewswire)
May-10-24 08:00AM	Liquidia Announces Poster Presentation at the American Thoracic Society (ATS) 2024 International Conference on Its Open-Label Safety Study of L606 (Liposomal Treprostinil) in Patients with PAH and PH-ILD (GlobeNewswire)
May-07-24 08:30AM	Liquidia Corporation to Present at BofA Securities Health Care Conference 2024 (GlobeNewswire)
08:00AM	Liquidia Corporation to Report First Quarter 2024 Financial Results on May 14, 2024 (GlobeNewswire)
Apr-25-24 10:02AM	Earnings Preview: Liquidia Technologies, Inc. (LQDA) Q1 Earnings Expected to Decline (Zacks)
Apr-02-24 09:00AM	Liquidia Corporation to Present at 23rd Annual Needham Virtual Healthcare Conference (GlobeNewswire)
Apr-01-24 06:00AM	Update on Favorable Legal and Regulatory Outcomes Clearing Path for Potential FDA approval of YUTREPIA (treprostinil) inhalation powder (GlobeNewswire)
Mar-20-24 01:50AM	Chief Medical Officer Rajeev Saggar Sells Shares of Liquidia Corp (LQDA) (GuruFocus.com)
01:49AM	Insider Sell: CFO and COO Michael Kaseta Sells 12,166 Shares of Liquidia Corp (LQDA) (GuruFocus.com)
Mar-16-24 02:42PM	Liquidia Corporation (NASDAQ:LQDA) Q4 2023 Earnings Call Transcript (Insider Monkey)
Mar-13-24 10:54PM	Q4 2023 Liquidia Corp Earnings Call (Thomson Reuters StreetEvents) +5.36%
07:31AM	Liquidia Corp (LQDA) Reports Full Year 2023 Financial Results (GuruFocus.com)
07:10AM	Liquidia Technologies, Inc. (LQDA) Reports Q4 Loss, Lags Revenue Estimates (Zacks)
06:00AM	Liquidia Corporation Reports Full Year 2023 Financial Results and Provides Corporate Update (GlobeNewswire)
Mar-06-24 06:30AM	Liquidia Corporation to Report Full Year 2023 Financial Results on Wednesday, March 13, 2024 (GlobeNewswire)
Feb-21-24 03:17PM	United Therapeutics' Challenges FDA Over Liquidia's Drug Approval Process, Clocks Strong Q4 Earnings (Benzinga)
06:51AM	UPDATE 3-United Therapeutics starts litigation with FDA over rival Liquidia's drug application (Reuters)
06:24AM	United Therapeutics, in unusual step, sues FDA over rivals drug application (BioPharma Dive)
Jan-30-24 06:30AM	Liquidia Corporation Announces Poster Presentation at the Pulmonary Vascular Research Institute 2024 Annual Congress (GlobeNewswire)
Jan-29-24 09:55AM	Wall Street Analysts Think Liquidia Technologies, Inc. (LQDA) Could Surge 71.41%: Read This Before Placing a Bet (Zacks)
Jan-25-24 06:25AM	UPDATE 1-US FDA still reviewing Liquidia's inhaled blood pressure drug (Reuters)
06:00AM	Liquidia Corporation Provides Update on New Drug Application for YUTREPIA (treprostinil) inhalation powder (GlobeNewswire)
Jan-19-24 06:30AM	Liquidia Corporation Announces Updates to Operations Leadership (GlobeNewswire)
Jan-09-24 06:21PM	Wall Street Analysts Believe Liquidia Technologies, Inc. (LQDA) Could Rally 29.94%: Here's is How to Trade (Zacks)
04:56PM	What Makes Liquidia Technologies, Inc. (LQDA) a Strong Momentum Stock: Buy Now? (Zacks)
Jan-08-24 08:22AM	Liquidia Corporation Files Response to United Therapeutics Lawsuit and Files Counterclaims (GlobeNewswire)
Jan-05-24 06:45AM	Liquidia Provides Update on Clinical Pipeline Targeting PAH and PH-ILD (GlobeNewswire)
Jan-04-24 09:10AM	Liquidia Corporation Announces $100 Million in New Financings (GlobeNewswire) +7.97%
Jan-02-24 06:45AM	Liquidia Corporation to Present at 42nd Annual J.P. Morgan Healthcare Conference (GlobeNewswire)
Dec-29-23 06:45AM	16 Most Promising Long-Term Stocks According to Analysts (Insider Monkey)
Dec-25-23 08:00AM	Biotech CEOs Are Buying Up Their Surging Stocks (Barrons.com)
Dec-22-23 06:35PM	Peabody Energy, Janus International, and More Stocks See Action From Activist Investors (Barrons.com)
Dec-20-23 04:56PM	U.S. Federal Circuit Affirms Earlier PTAB Decision to Invalidate All Claims of United Therapeutics Patent No. 10,716,793 ('793 Patent) (GlobeNewswire) +35.70% +5.33%
Dec-19-23 01:02PM	Insider Sell Alert: Chief Medical Officer Rajeev Saggar Sells 14,887 Shares of Liquidia Corp (LQDA) (GuruFocus.com) +5.63%
Dec-12-23 07:13AM	Liquidia Announces Pricing of Public Offering of Common Stock (GlobeNewswire)
Nov-08-23 10:47AM	Liquidia Corporation (NASDAQ:LQDA) Q3 2023 Earnings Call Transcript (Insider Monkey)
12:44AM	Q3 2023 Liquidia Corp Earnings Call (Thomson Reuters StreetEvents)
Nov-07-23 07:07AM	Liquidia Corp (LQDA) Reports Q3 2023 Financial Results (GuruFocus.com)
06:30AM	Liquidia Corporation Reports Third Quarter 2023 Financial Results and Provides Corporate Update (GlobeNewswire)
Oct-31-23 06:30AM	Liquidia Corporation to Report Third Quarter 2023 Financial Results on November 7, 2023 (GlobeNewswire)
Oct-02-23 07:00AM	Emergent BioSolutions Names Two Pharmaceutical Industry Veterans to Board of Directors (GlobeNewswire)
Sep-25-23 04:09PM	FDA Accepts Submission to Add PH-ILD to YUTREPIA Label (GlobeNewswire)
Sep-06-23 04:30PM	United Therapeutics Corporation Files Lawsuit Alleging Infringement of Tyvaso Patent Already Found to Be Invalid by U.S. Patent Office (GlobeNewswire)
Aug-13-23 05:22AM	Liquidia Corporation (NASDAQ:LQDA) Q2 2023 Earnings Call Transcript (Insider Monkey)
Aug-11-23 12:38AM	Q2 2023 Liquidia Corp Earnings Call (Thomson Reuters StreetEvents) -9.13%
Aug-10-23 07:15AM	Liquidia Technologies, Inc. (LQDA) Reports Q2 Loss, Tops Revenue Estimates (Zacks)
06:00AM	Liquidia Corporation Reports Second Quarter 2023 Financial Results and Provides Corporate Update (GlobeNewswire)
Aug-03-23 08:17AM	Liquidia Corporation to Report Second Quarter 2023 Financial Results on August 10, 2023 (GlobeNewswire)
Jul-27-23 09:13AM	Liquidia Stock Down 12% But Insiders Still In US$74k Profit (Simply Wall St.)
06:00AM	Liquidia Submits Amendment to Add PH-ILD Indication to Tentatively Approved NDA for YUTREPIA (treprostinil) Inhalation Powder (GlobeNewswire)
Jul-25-23 02:37PM	Liquidia stock drops after setback in United Therapeutics dispute (American City Business Journals)
08:25AM	Silver Spring's United Therapeutics claims victory in patent infringement suit against Liquidia (American City Business Journals)
Jul-24-23 01:46PM	U.S. Federal Circuit Affirms All District Court Rulings in Patent Litigation (GlobeNewswire) -12.76%
Jun-29-23 11:24AM	Liquidia (LQDA) Up on Deal With Pharmosa to Co-Develop PH Drug (Zacks) -17.68%
Jun-28-23 05:36AM	Liquidia Corporation and Pharmosa Biopharm Announce Collaboration for Sustained-Release Inhaled Treprostinil Product in North America (GlobeNewswire) +10.99%
May-31-23 06:30AM	Liquidia Corporation to Present at the 2023 Jefferies Healthcare Conference (GlobeNewswire)
May-30-23 11:26AM	Investing in Liquidia (NASDAQ:LQDA) a year ago would have delivered you a 106% gain (Simply Wall St.)
May-21-23 03:39PM	Hero or Zero? 7 High-Risk Stocks to Make You Rich Or Broke. (InvestorPlace)
May-19-23 06:15AM	Liquidia Announces Poster Presentation at the 2023 American Thoracic Society International Conference (GlobeNewswire) +6.14%

Liquidia Corp. operates as a holding company which through its subsidiary engages in developing and commercializing biopharmaceutical products. It engages in novel products development used in PRINT technology to transform the lives of patients. The company was founded on June 28, 2020, and is headquartered in Morrisville, NC.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Moomaw Scott	Chief Commercial Officer	Dec 02 '24	Sale	11.51	546	6,284	154,127	Dec 03 09:45 PM
Kaseta Michael	CFO and COO	Dec 02 '24	Sale	11.51	1,091	12,557	312,328	Dec 03 09:44 PM
Schundler Russell	General Counsel	Dec 02 '24	Sale	11.51	1,063	12,235	487,328	Dec 03 09:43 PM
Adair Jason	Chief Business Officer	Dec 02 '24	Sale	11.51	455	5,237	119,223	Dec 03 09:43 PM
Saggar Rajeev	Chief Medical Officer	Oct 18 '24	Sale	11.19	2,526	28,266	204,857	Oct 22 04:15 PM
Schundler Russell	General Counsel	Oct 14 '24	Sale	11.11	2,576	28,613	486,048	Oct 15 08:12 PM
Saggar Rajeev	Chief Medical Officer	Oct 14 '24	Sale	11.11	2,260	25,103	207,383	Oct 15 08:11 PM
Moomaw Scott	Chief Commercial Officer	Oct 14 '24	Sale	11.11	1,527	16,961	152,798	Oct 15 08:10 PM
Kaseta Michael	CFO and COO	Oct 14 '24	Sale	11.11	3,892	43,231	311,076	Oct 15 08:08 PM
JEFFS ROGER	Chief Executive Officer	Oct 14 '24	Sale	11.11	8,053	89,450	812,193	Oct 15 08:06 PM
Adair Jason	Chief Business Officer	Oct 14 '24	Sale	11.11	1,146	12,729	118,574	Oct 15 08:06 PM
Manning Paul B	Director	Sep 12 '24	Buy	8.90	337,078	2,999,994	816,311	Sep 16 04:05 PM
Caligan Partners LP	Director	Aug 30 '24	Buy	9.51	150,000	1,426,500	6,994,997	Sep 04 05:51 PM
Caligan Partners LP	Director	Aug 30 '24	Sale	9.51	150,000	1,426,500	6,844,997	Sep 04 05:51 PM
Adair Jason	Chief Business Officer	Sep 03 '24	Sale	9.50	455	4,322	115,814	Sep 04 04:51 PM
Schundler Russell	General Counsel	Sep 03 '24	Sale	9.50	710	6,745	488,624	Sep 04 04:44 PM
Moomaw Scott	Chief Commercial Officer	Sep 03 '24	Sale	9.50	546	5,187	154,325	Sep 04 04:44 PM
Kaseta Michael	CFO and COO	Sep 03 '24	Sale	9.50	1,079	10,250	314,968	Sep 04 04:40 PM
Adair Jason	Chief Business Officer	Jul 26 '24	Sale	11.44	1,833	20,970	113,393	Jul 29 04:30 PM
Saggar Rajeev	Chief Medical Officer	Jul 19 '24	Sale	11.13	1,873	20,846	208,329	Jul 22 04:30 PM
JEFFS ROGER	Chief Executive Officer	Jul 12 '24	Sale	12.53	8,053	100,904	818,932	Jul 15 06:32 PM
Moomaw Scott	Chief Commercial Officer	Jul 12 '24	Sale	12.53	1,528	19,146	151,682	Jul 15 06:30 PM
Adair Jason	Chief Business Officer	Jul 12 '24	Sale	12.53	1,146	14,359	115,226	Jul 15 06:28 PM
Schundler Russell	General Counsel	Jul 12 '24	Sale	12.53	1,985	24,872	485,676	Jul 15 06:27 PM
Saggar Rajeev	Chief Medical Officer	Jul 12 '24	Sale	12.53	1,470	18,419	210,202	Jul 15 06:25 PM
Kaseta Michael	CFO and COO	Jul 12 '24	Sale	12.53	3,906	48,942	312,389	Jul 15 06:23 PM
Kaseta Michael	CFO and COO	Jun 03 '24	Sale	14.55	1,094	15,918	316,295	Jun 04 09:26 PM
Adair Jason	Chief Business Officer	Jun 03 '24	Sale	14.55	455	6,620	112,465	Jun 04 09:26 PM
Schundler Russell	General Counsel	Jun 03 '24	Sale	14.55	710	10,330	487,661	Jun 04 09:25 PM
Moomaw Scott	Chief Commercial Officer	Jun 03 '24	Sale	14.55	546	7,944	153,210	Jun 04 09:24 PM
Saggar Rajeev	Chief Medical Officer	Apr 19 '24	Sale	13.68	1,649	22,558	211,672	Apr 23 05:24 PM
Schundler Russell	General Counsel	Apr 12 '24	Sale	14.58	2,060	30,035	486,027	Apr 16 05:17 PM
Saggar Rajeev	Chief Medical Officer	Apr 12 '24	Sale	14.58	1,525	22,234	213,321	Apr 16 05:17 PM
Moomaw Scott	Chief Commercial Officer	Apr 12 '24	Sale	14.58	1,585	23,109	151,881	Apr 16 05:16 PM
Kaseta Michael	CFO and COO	Apr 12 '24	Sale	14.58	3,136	45,723	315,045	Apr 16 05:16 PM
JEFFS ROGER	Chief Executive Officer	Apr 12 '24	Sale	14.58	8,360	121,889	826,985	Apr 16 05:15 PM
Adair Jason	Chief Business Officer	Apr 12 '24	Sale	14.58	1,189	17,336	111,537	Apr 15 08:31 PM
Adair Jason	Chief Business Officer	Mar 18 '24	Sale	15.81	4,657	73,649	108,640	Mar 19 09:50 PM
Schundler Russell	General Counsel	Mar 18 '24	Sale	15.82	8,653	136,890	488,087	Mar 19 09:48 PM
Moomaw Scott	Chief Commercial Officer	Mar 18 '24	Sale	15.82	6,108	96,629	153,466	Mar 19 09:47 PM
Kaseta Michael	CFO and COO	Mar 18 '24	Sale	15.82	12,166	192,466	318,181	Mar 19 09:47 PM
Saggar Rajeev	Chief Medical Officer	Mar 18 '24	Sale	15.82	7,530	119,125	214,846	Mar 19 09:46 PM
JEFFS ROGER	Chief Executive Officer	Mar 18 '24	Sale	15.82	28,583	452,183	835,345	Mar 19 09:46 PM
Moomaw Scott	Chief Commercial Officer	Feb 29 '24	Sale	14.17	546	7,737	159,574	Mar 04 07:07 PM
Adair Jason	Chief Business Officer	Feb 29 '24	Sale	14.17	455	6,447	97,412	Mar 04 07:05 PM
Adair Jason	Chief Business Officer	Dec 18 '23	Sale	7.70	77	593	54,932	Dec 20 05:20 PM
JEFFS ROGER	Chief Executive Officer	Dec 14 '23	Buy	7.16	139,665	1,000,001	640,805	Dec 18 05:02 PM
Manning Paul B	Director	Dec 14 '23	Buy	7.16	279,330	2,000,003	279,330	Dec 18 05:00 PM
Caligan Partners LP	Director	Dec 14 '23	Buy	7.16	1,117,318	7,999,997	11,280,945	Dec 14 04:42 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

LQDA

Liquidia Corp

Upgrade your FINVIZ experience